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Type 1 diabetes is a complex disease requiring insulin 
administration in conjunction with an individual 
meal plan that takes into consideration social, 
economic and logistical factors to achieve optimal 
diabetes control. Short-term goals are to ensure 
normal growth and development, while minimising complications 
such as hyper- and hypoglycaemia. Long-term goals are to achieve 
blood sugars as close to the normal range as possible, to prevent or 
delay devastating long-term complications. 
The diabetes control and complication trial (DCCT) proved that 
lowering haemoglobin A1C (HbA1c) through intensive management 
effectively delayed the onset and slowed the progression of diabetic 
retinopathy, nephropathy and neuropathy.[1] Further analysis of DCCT 
trial data and other evidence suggests that glycaemic variability 
contributes to diabetes complications independently of the HbA1c.[2,3]
The contribution of postprandial hyperglycaemia to the average 
blood glucose level, measured by HbA1c, increases in an inverse 
relationship to HbA1c.[4] Reducing postprandial hyperglycaemia 
is essential to achieving the published target of <7% HbA1c.[4] 
Furthermore, a rise in postprandial glucose (PPBG) is an independent 
risk factor for cardiovascular events.[5] In well-controlled patients, it 
is a stronger predictor of cardiovascular disease than elevations of 
fasting blood glucose.[6] Thus, PPBG concentrations, which contribute 
significantly to average blood-glucose measurements, may well be an 
independent risk factor for other diabetic complications and need to 
be targeted independently of the mean blood sugar, as measured by 
the HbA1c.
Dietary management in diabetes aims to provide the recommended 
daily intake of energy and macro- and micronutrients, while minimising 
glucose exposure and fluctuations. Dietary carbohydrate is the primary 
determinant of meal-related blood-glucose excursions and is dependent 
on the glycaemic index (GI) and the overall load of carbohydrate 
consumed.[7] Patients with diabetes have a higher and more prolonged 
postprandial glucose excursion due to abnormalities in insulin, glucagon 
and amylin secretion, hepatic and peripheral glucose uptake, and 
suppression of hepatic glucose production.[7] A tighter match between 
insulin action and carbohydrate delivery will improve blood-glucose 
control while reducing the occurrence of both hyper- and hypoglycaemia.
Carbohydrate counting is a method that matches carbohydrate intake 
with insulin delivery and has been shown to offer an advantage in terms 
of greater reduction in HbA1c than standard meal planning.[8] The 
American Diabetes Association currently recommends that prandial 
insulin dosing is based on the total carbohydrate content of the meal, but 
consideration should be given to the GI and glycaemic load of the meal.[9]
Following the DCCT trial, intensified insulin therapy is the gold 
standard for managing diabetes and forms the backbone of most modern 
insulin regimens. The majority of modern insulin regimens and bolus 
advisors use some form of carbohydrate counting and a linear algorithm 
to match bolus mealtime insulin to the amount of carbohydrate eaten. 
Previous euglycaemic clamp studies found a linear relationship 
between the insulin infused and carbohydrate load.[10] However, 
significant differences exist between the pharmacokinetic and 
pharmacodynamic properties of subcutaneously injected bolus 
insulin and continuous intravenous insulin infusions. 
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Background. Postprandial glucose excursions contribute significantly to average blood glucose, glycaemic variability and cardiovascular risk. 
Carbohydrate counting is a method of insulin dosing that balances carbohydrate load to insulin dose using a fixed ratio. Many patients and current 
insulin pumps calculate insulin delivery for meals based on a linear carbohydrate-to-insulin relationship. It is our hypothesis that a non-linear 
relationship exists between the amounts of carbohydrate consumed and the insulin required to cover it. 
Aim. To document blood glucose exposure in response to increasing carbohydrate loads on fixed carbohydrate-to-insulin ratios.
Methods. Five type 1 diabetic subjects receiving insulin pump therapy with good control were recruited. Morning basal rates and carbohydrate-
to-insulin ratios were optimised. A Medtronic glucose sensor was used for 5 days to collect data for area-under-the-curve (AUC) analysis, 
during which standardised meals of increasing carbohydrate loads were consumed.
Results. Increasing carbohydrate loads using a fixed carbohydrate-to-insulin ratio resulted in increasing glucose AUC. The relationship was found 
to be exponential rather than linear. Late postprandial hypoglycaemia followed carbohydrate loads of >60 g and this was often followed by rebound 
hyperglycaemia that lasted >6 hours.
Conclusion. A non-linear relationship exists between carbohydrates consumed and the insulin required to cover them. This has implications for 
control of postprandial blood sugars, especially when consuming large carbohydrate loads. Further studies are required to look at the optimal 
ratios, duration and type of insulin boluses required to cover increasing carbohydrate loads. 
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Based on our clinical experience, we hypothesised that a non-linear 
relationship exists between the amount of carbohydrate consumed 
and the insulin ratio required to cover it when using pre-meal 
subcutaneous bolus insulin. No previous studies have been done 
using subcutaneously injected insulin to examine the relationship 
between the amount of carbohydrate consumed and the amount of 
insulin required to maintain euglycaemia. 
According to our hypothesis, as the carbohydrate load increases, 
the amount of insulin required will increase exponentially rather than 
linearly. To test this we used real-time continuous glucose monitoring 
to assess blood-glucose exposure, using fixed carbohydrate ratios 
with the delivery of increasing carbohydrate loads.
Methods
Study design and subjects
We performed an analytical observational study on 5 type 1 diabetic 
adolescents and young adults receiving insulin pump therapy with good 
control and stable carbohydrate-to-insulin ratios attending the Centre 
for Diabetes and Endocrinology at the Donald Gordon Medical Centre, 
Johannesburg, South Africa. Average participant age was 21.4 years 
(range 14 - 30), with a mean duration of diabetes of 8.4 years (4 - 20). The 
mean HbA1c of the participants was 7.1% (6.8 - 7.4%).
Participants’ basal rates and carbohydrate ratios were optimised 
prior to the study. A Medtronic continuous glucose monitoring system 
(CGMS) (Medtronic Minimed, USA) was inserted and calibrated for 
each participant on the first day. Participants continued regular self-
monitoring blood glucose checks and calibration checks.
For 5 consecutive days the participants ate, in random order, a pre-
prepared breakfast of 30 g, 60 g, 90 g, 120 g and 150 g carbohydrate 
(2C, 4C, 6C, 8C, 10C meals, respectively) (Table 1). The content was 
calculated and prepared by a registered dietician. The participants 
ate breakfast at the same time on each study day and gave themselves 
a bolus of insulin 15 minutes before eating, according to their pre-
determined carbohydrate-to-insulin ratios. At the end of the 5-day 
period, the CGMS was removed and the data downloaded using 
Medtronic Solutions software. Each participant performed the 5-day 
study procedure twice so that inter- and intra-patient variability could 
be compared. 
The glucose level was captured every 5 minutes from baseline to the 
peak of glucose absorption and back to baseline (Fig. 1). The area under 
the curve (AUC) was calculated for each meal for each participant, 
representing the ‘incremental glucose area’ or postprandial glucose 
exposure. The AUC for blood-glucose excursion was compared for the 
5 different meals. The maximal change in glucose for each meal was 
documented, as was the time taken to reach this glucose level and the 
time taken for glucose level to return to baseline.
Statistical analysis
A straight line was fitted to the log data using an analysis of covariance, 
allowing for possible differences between the 5 individual participants. 
P-values were determined to assess the significance of the fit of the 
line. Predicted values were obtained from the fitted model. A one-way 
randomised blocks design was used to determine the significance of 
the maximal change in glucose for each meal, the time to maximum 
glucose and the time taken for glucose to return to baseline.
Results
There was a significant increase (p<0.0002) in the peak glucose and 
time to return to baseline (p<0.002) as carbohydrate loads increased, 
without a significant increase in time to peak levels. The AUC for each 
participant for each meal increased with increasing carbohydrate load, 
with an exponential rather than linear trend (Fig. 2) – confirmed by 
Table 1. Nutritional content of each meal
Carbohydrate meals
n
Carbohydrate 
g
Nutren Diabetes*
ml (g) 
Fruit squares†
n (g)
Marie biscuits‡
n (g)
Protein content
g
Fat content
g
2 30 75 (15) 5 (10) 1 (5) 1.55 1.04
4 60 150 (30) 10 (20) 2 (10) 3.30 2.08
6 90 225 (45) 15 (30) 3 (15) 4.95 3.12
8 120 300 (60) 20 (40) 4 (20) 6.60 4.16
10 150 375 (75) 25 (50) 5 (25) 8.25 5.20
Carbohydrate, % - 50 33 17 - -
*11 g carbohydrate/100 ml, 9% glucose polymer.
†2 g carbohydrate/square.
‡5 g carbohydrate/biscuit.
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Fig. 1. Blood glucose levels for a single participant’s 5-day study period. Each 
line represents a different carbohydrate meal (2C, 4C, 6C, 8C, 10C).
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Fig. 2. Area under the curve (AUC) for each meal (carbohydrate load) for 
participants 1 - 5.
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the significant linear relationship between the natural logarithm of the 
AUC and the carbohydrate load for each participant, as well as for the 
average of all 5 participants (p<0.0001). An analysis of covariance did 
not reveal any significant differences between the participants. 
The 2C and 4C meals showed a delay in time from eating to the 
start of the glucose rise and a smaller AUC. The 6C, 8C and 10C 
meals showed an earlier rise in blood glucose. There was an increase 
in time to maximum glucose from baseline, a greater peak and 
delayed return to baseline with these larger carbohydrate loads.
Following the higher glucose peak of the larger carbohydrate 
meals (6C, 8C and 10C meals; >60 g carbohydrate), the glucose level 
frequently dropped below baseline and often fell to the hypoglycaemic 
range (<3.5 mmol/l). This drop in glucose level, which was untreated 
in the study participants, rebounded and remained high for up to 
6 hours. This high, followed by a low, followed by a high, shows a 
pattern of increasing glycaemic variability. 
Discussion
Our analysis convincingly demonstrates that the AUC increases 
exponentially, and not linearly, with increasing carbohydrate 
load over the range of carbohydrate loads tested. This is the first 
study to document that, when using subcutaneous insulin, the 
linear algorithms used to calculate carbohydrate-to-insulin ratios 
may contribute to increased postprandial glucose excursions and 
variability when high carbohydrate loads are consumed. 
This has implications for diabetics who use carbohydrate counting 
and carbohydrate-to-insulin ratios based on a linear algorithm to 
calculate pre-meal insulin doses. All ‘smart’ insulin pumps and ‘bolus 
advisors’ base their calculations on this linear algorithm.
Subcutaneously injected insulin has different pharmacokinetic 
properties to intravenously injected insulin with regard to onset of 
action, peak action and duration of action. As a result, studies that 
use intravenous insulin to derive the linear algorithm cannot be 
extrapolated to subcutaneously injected insulin. 
The increase in postprandial blood sugars with the 6C - 10C meals 
is clinically significant and would contribute to higher HbA1c levels 
and cardiovascular risk.[4,5] Higher postprandial glucose excursions with 
subsequent falls in blood glucose into the hypoglycaemic range and the 
rebound hyperglycaemia increase glucose variability. Both an increase 
in HbA1c and an increase in glucose variability have been shown to 
contribute to an increased risk of developing diabetic complications.[1-3]
The delayed hypoglycaemia following the 6C - 10C meals has 
significant implications for management of these postprandial 
glucose excursions. Extrapolating from the exponential relationship, 
an exponentially larger dose of insulin would be required to prevent 
the postprandial glucose rise. However, owing to the pharmacokinetic 
properties of subcutaneous insulin and the finding of delayed 
hypoglycaemia, it is possible to deduce that this would only lead to 
a greater frequency and severity of late postprandial hypoglycaemia.
There are a few possible management options for controlling the 
postprandial hyperglycaemia observed with larger carbohydrate meals:
• Limit carbohydrate intake at each meal to a maximum of 4C. We 
have shown that the glucose excursion after ingesting up to 4C (60g 
carbohydrate) can be limited by preprandial subcutaneous insulin 
using fixed insulin-to-carbohydrate ratios and that the slope of the 
curve is more linear in this range. Low carbohydrate diets have proven 
efficacy in reducing postprandial glucose levels, HbA1c and frequency 
of hypoglycaemic episodes.[11] Low carbohydrate diets limit total daily 
intake to ≤70 - 90 g carbohydrate. These strict targets are difficult to 
maintain over the long term and, based on our data, less stringent 
carbohydrate targeting could be recommended, provided that meals 
>4C are avoided. 
• Administer prandial insulin 20 - 30 min before the meal to ensure 
sufficient insulin to meet and store the incoming carbohydrates.
• Change the pharmacokinetics of the injected insulin to accelerate its 
absorption or change its delivery profile. The newly developed heating 
patch, InsuPatch, has significant effects on the pharmacokinetics 
of insulin analogues and PPBG.[12] Patients receiving insulin pump 
therapy can change the duration over which their pre-meal insulin 
is injected. Insulin can be injected using a ‘square wave’ bolus, where 
the total amount of insulin is infused over a set time period, or a ‘dual 
wave’ bolus, where a percentage of the dose can be injected pre-meal 
and the remaining percentage infused over a set time period Both the 
percentage injected and the time period over which it is injected can 
be adjusted.[13] Newer, faster-acting insulins are also being developed 
that hold promise for PPBG control. 
• Recommend the consumption of lower GI carbohydrates, which have 
been shown to lower PPBG.[14]
This study is limited in that only 5 subjects were involved. Further studies 
are required to determine the optimal ratios of insulin, insulin delivery 
options and non-insulin-related strategies for managing PPBG. Our 
study’s strength lies in showing the importance of insulin dose regulation 
by diabetics according to the carbohydrate loads consumed.
Conclusion
To prevent complications of diabetes, patients need to reduce their 
average blood sugars, as measured by HbA1c, and their glycaemic 
variability to as close to the non-diabetic range as possible. PPBG levels 
contribute significantly to HbA1c and glycaemic variability, hence 
the importance of optimally limiting post-meal glucose excursions. 
Dietary carbohydrate is the primary determinant of PPBG excursions 
with preprandial bolus insulin primarily governing the excursion of 
postprandial glucose.
We have shown that the consumption of an increasing carbohydrate 
load leads to an exponential increase in postprandial glucose 
exposure when using a linear algorithm to determine the insulin-to-
carbohydrate ratio after subcutaneous insulin injection, and increases 
the risk for delayed postprandial hyper- and hypoglycaemia.
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